1454844-96-2

Upstream product

• 660397-48-8 14-bromo-3,11-diisopropoxy-2,12-dimethoxy-8,9-dihydro-6H-[1]benzopyrano[4’,3’:4,5]pyrrolo[2,1-a]isoquinolin-6-one 
• 319472-55-4 3-methoxy-4-(methoxymethoxy)benzene-boronic acid 
• 660397-47-7 8,9-dihydro-3,11-diisopropoxy-2,12-dimethoxy-6H-[1]benzopyrano[4',3':4,5]pyrrolo[2,1-a]isoquinolin-6-one 

Downstream Products

• 1454845-05-6 3,11-diisopropoxy-2,12-dimethoxy-14-[4-methoxy-3-(methoxymethoxy)phenyl]-6H-[1]benzopyrano[4′,3′:4,5]-pyrrolo[2,1-a]isoquinolin-6-one 
• 1454845-06-7 14-(3-hydroxy-4-methoxyphenyl)-3,11-diisopropoxy-2,12-dimethoxy-6H-[1]benzopyrano[4′,3':4,5]pyrrolo[2,1-a]-isoquinolin-6-one 

Relevant academic research and scientific papers

Synthesis, resolution, and biological evaluation of atropisomeric (aR)- and (aS)-16-methyllamellarins N: Unique effects of the axial chirality on the selectivity of protein kinases inhibition

The total synthesis of the optically active (aR)- and (aS)-16- methyllamellarins N (3a and 3b) was achieved via resolution on HPLC chiral stationary phase. The kinase inhibitory activities of both enantiomers were evaluated on eight protein kinases releva